Search

Your search keyword '"Double KL"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Double KL" Remove constraint Author: "Double KL"
150 results on '"Double KL"'

Search Results

1. Empirically derived formulae for calculation of age- and region-related levels of iron, copper and zinc in the adult C57BL/6 mouse brain

2. A brief history of brain iron accumulation in Parkinson disease and related disorders.

3. Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord.

4. Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic

5. Simultaneous structural and elemental nano-imaging of human brain tissue

7. Simultaneous structural and elemental nano-imaging of human brain tissue

8. Meta-analysis of copper and iron in Parkinson's disease brain and biofluids

9. Reduction in IGF1 mRNA in the human subependymal zone during aging

10. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

11. A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress

14. Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

15. Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers

16. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain

17. Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease

18. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain

19. Iron and dopamine: A toxic couple

20. Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence Microscopy

21. Decline in proliferation and immature neuron markers in the human subependymal zone during aging: Relationship to EGF- and FGF-related transcripts

22. L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro

23. Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway

24. Hand function is impaired in healthy older adults at risk of Parkinson’s disease

25. Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model

26. Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease

27. Localization of copper and copper transporters in the human brain

28. Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra

29. L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro

31. The background and experience of neuroscience teachers in Australian universities: A cross-sectional survey.

32. Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu 2+ in the Brain.

33. Empirically derived formulae for calculation of age- and region-related levels of iron, copper and zinc in the adult C57BL/6 mouse brain.

34. Responsible research practices could be more strongly endorsed by Australian university codes of research conduct.

35. A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.

36. Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity.

37. Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord.

38. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.

39. Empirical evidence for biometal dysregulation in Parkinson's disease from a systematic review and Bradford Hill analysis.

40. A brief history of brain iron accumulation in Parkinson disease and related disorders.

41. Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological Workflow.

42. Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic.

43. Measurement of the adult human midbrain with transcranial ultrasound.

44. Meta-Analysis of Copper and Iron in Parkinson's Disease Brain and Biofluids.

45. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.

46. Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.

47. Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.

48. Reduction in IGF1 mRNA in the Human Subependymal Zone During Aging.

49. A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress.

Catalog

Books, media, physical & digital resources